Literature DB >> 9660432

Dimeric inhibin: a direct marker of ovarian aging.

D R Danforth1, L K Arbogast, J Mroueh, M H Kim, E A Kennard, D B Seifer, C I Friedman.   

Abstract

OBJECTIVE: To investigate whether luteal secretion of inhibin-a is altered in the perimenopausal transition and to evaluate whether luteal inhibin secretion is correlated with other markers of ovarian reserve such as FSH and inhibin-b.
DESIGN: Prospective study.
SETTING: Reproductive Endocrinology Laboratories at The Ohio State University. PATIENT(S): Twenty-five women 39-52 years of age with regular menstrual cycles. INTERVENTION(S): Daily urine samples were monitored (LH predictor kit) to identify the day of ovulation. Blood samples obtained on days 6 and 8 after the LH surge and on day 3 of the subsequent follicular phase were assayed for FSH, E2, progesterone. inhibin-a, and inhibin-b. MAIN OUTCOME MEASURE(S): Serum levels of inhibin-a, inhibin-b, FSH, E2, and progesterone. RESULT(S): Luteal phase inhibin-a and follicular phase inhibin-b were correlated inversely with age in perimenopausal women. In addition, luteal phase inhibin-a and follicular phase inhibin-b levels were correlated inversely with follicular phase FSH levels. CONCLUSION(S): Both luteal phase inhibin-a and follicular phase inhibin-b levels are correlated inversely with age during the fifth decade of life. These findings suggest that corpus luteum function is altered during the perimenopausal transition. Moreover, these direct measures of ovarian function may be more sensitive indicators of "ovarian reserve" than indirect indicators such as pituitary FSH secretion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660432     DOI: 10.1016/s0015-0282(98)00127-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

1.  Periovulatory serum inhibin-a in women with a diminished ovarian reserve.

Authors:  S R Lindheim; M A Cohen; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

2.  Ovarian reserve tests and their utility in predicting response to controlled ovarian stimulation in rhesus monkeys.

Authors:  Julie M Wu; Diana L Takahashi; Donald K Ingram; Julie A Mattison; George Roth; Mary Ann Ottinger; Mary B Zelinski
Journal:  Am J Primatol       Date:  2010-08       Impact factor: 2.371

3.  Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome.

Authors:  Jan R Mellembakken; Sarah L Berga; Mirjam Kilen; Tom G Tanbo; Thomas Abyholm; Peter Fedorcsák
Journal:  Hum Reprod       Date:  2011-06-30       Impact factor: 6.918

Review 4.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

5.  A characterization of the relationship of ovarian reserve markers with age.

Authors:  Mitchell P Rosen; Erica Johnstone; Charles E McCulloch; Sonya M Schuh-Huerta; Barbara Sternfeld; Renee A Reijo-Pera; Marcelle I Cedars
Journal:  Fertil Steril       Date:  2011-11-30       Impact factor: 7.329

Review 6.  Reproductive hormones and the menopause transition.

Authors:  Nanette Santoro; John F Randolph
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

Review 7.  Pregnancy-induced changes in breast cancer risk.

Authors:  Irma H Russo; Jose Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09       Impact factor: 2.673

8.  Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan.

Authors:  Rahul Rai; Asish K Ghosh; Mesut Eren; Alexander R Mackie; Daniel C Levine; So-Youn Kim; Jonathan Cedernaes; Veronica Ramirez; Daniele Procissi; Layton H Smith; Teresa K Woodruff; Joseph Bass; Douglas E Vaughan
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

Review 9.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.

Authors:  Kristy M Nicks; Daniel S Perrien; Nisreen S Akel; Larry J Suva; Dana Gaddy
Journal:  Mol Cell Endocrinol       Date:  2009-07-15       Impact factor: 4.102

10.  Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.

Authors:  MaryFran R Sowers; Aimee D Eyvazzadeh; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Daowen Zhang; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.